Physitrack Bilan de santé

Santé financière contrôle des critères 3/6

Physitrack possède un total de capitaux propres de €25.1M et une dette totale de €4.9M, ce qui porte son ratio d'endettement à 19.3%. Son actif total et son passif total sont €38.7M et de €13.6M.

Informations clés

19.3%

Ratio d'endettement

€4.85m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	€521.95k
Fonds propres	€25.09m
Total du passif	€13.64m
Total des actifs	€38.73m

Mises à jour récentes de la santé financière

Physitrack (STO:PTRK) Has A Somewhat Strained Balance Sheet

Apr 10

Recent updates

Investors Shouldn't Be Too Comfortable With Physitrack's (STO:PTRK) Earnings

Nov 20

Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

Nov 13

Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

Nov 13

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de PTRK ( €4.5M ) ne couvrent pas ses passifs à court terme ( €5.2M ).

Passif à long terme: Les actifs à court terme de PTRK ( €4.5M ) ne couvrent pas ses passifs à long terme ( €8.4M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de PTRK ( 17.3% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de PTRK a été réduit de 38.2% à 19.3% au cours des 5 dernières années.

Couverture de la dette: La dette de PTRK est bien couverte par le flux de trésorerie opérationnel ( 64.7% ).

Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de PTRK sur sa dette sont bien couverts par l'EBIT.

Physitrack Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Physitrack (STO:PTRK) Has A Somewhat Strained Balance Sheet

Recent updates

Investors Shouldn't Be Too Comfortable With Physitrack's (STO:PTRK) Earnings

Third quarter 2024 earnings released: €0.02 loss per share (vs €0.015 loss in 3Q 2023)

Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 22%

Chairman & Senior Independent Director recently bought kr51k worth of stock

Second quarter 2024 earnings released: €0.029 loss per share (vs €0.015 loss in 2Q 2023)

Investor sentiment improves as stock rises 16%

Investors Aren't Entirely Convinced By Physitrack PLC's (STO:PTRK) Revenues

Chairman & Senior Independent Director recently bought kr57k worth of stock

First quarter 2024 earnings released: €0.01 loss per share (vs €0.004 loss in 1Q 2023)

Investor sentiment improves as stock rises 16%

Physitrack (STO:PTRK) Is Doing The Right Things To Multiply Its Share Price

Physitrack (STO:PTRK) Has A Somewhat Strained Balance Sheet

New minor risk - Earnings quality

Investor sentiment deteriorates as stock falls 18%

Full year 2023 earnings released: EPS: €0.20 (vs €0.006 in FY 2022)

Physitrack PLC (STO:PTRK) Could Be Riskier Than It Looks

Physitrack PLC, Annual General Meeting, May 03, 2024

Physitrack PLC to Report Q4, 2024 Results on Feb 28, 2025

New minor risk - Share price stability

Third quarter 2023 earnings released: €0.01 loss per share (vs €0.001 profit in 3Q 2022)

Revenues Tell The Story For Physitrack PLC (STO:PTRK)

Why Physitrack PLC (STO:PTRK) Could Be Worth Watching

Second quarter 2023 earnings released: €0.015 loss per share (vs €0.026 loss in 2Q 2022)

New minor risk - Share price stability

Physitrack plc Announces Board Changes

Physitrack PLC Announces Appointment of Jack Goodwin as Head of People

Physitrack PLC Approves Election of Anne-Sophie D'andlau as Director

First quarter 2023 earnings released

Independent Non-Executive Director recently bought kr56k worth of stock

Consensus EPS estimates upgraded to €0.025 loss

Full year 2022 earnings released: EPS: €0.01 (vs €0.06 loss in FY 2021)

Be Wary Of Physitrack (STO:PTRK) And Its Returns On Capital

Physitrack PLC Appoints Nick McClelland to Take on A New Role as Chief Growth Officer

High number of new and inexperienced directors

Physitrack PLC Announces the Appoints Anne-Sophie d'Andlau as Board Member

Third quarter 2022 earnings released: EPS: €0.001 (vs €0.07 loss in 3Q 2021)

Physitrack PLC to Report Q2, 2023 Results on Aug 15, 2023

Physitrack (STO:PTRK) Will Be Hoping To Turn Its Returns On Capital Around

Henrik Molin, Chief Executive Officer and Co-founder of Physitrack PLC acquired an additional 4.3% stake in Physitrack PLC (OM : PTRK) from Nathan Skwortsow, co-founder of Physitrack PLC for €1 million.

Second quarter 2022 earnings released: €0.02 loss per share (vs €0.011 loss in 2Q 2021)

Physitrack plc Recruits Announces Management Changes

Chief Operating Officer recently bought kr56k worth of stock

First quarter 2022 earnings: Revenues miss analyst expectations

Physitrack PLC (OM:PTRK) acquired Champion Health Ltd from Harry Bliss and Ricky Bailey for £10.4 million.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Chief Financial Officer recently bought kr62k worth of stock

Physitrack PLC (OM:PTRK) acquired Wellnow Group GmbH from Axel Springer Plug and Play Accelerator GmbH and Tengelmann Ventures Management GmbH for €11.5 million.

Physitrack PLC (OM:PTRK) acquired Wellnow Group GmbH from Axel Springer Plug and Play Accelerator GmbH and Tengelmann Ventures Management GmbH for €11.5 million.

Full year 2021 earnings: EPS exceeds analyst expectations

Physitrack PLC Provides Earnings Guidance

Investor sentiment improved over the past week

Physitrack PLC has completed an IPO in the amount of SEK 175 million.

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines